Journal of the American College of Surgeons
Volume 208, Issue 1 , Pages 110-119 , January 2009

Stored Red Blood Cell Transfusion Induces Regulatory T Cells

  • Joel M. Baumgartner, MD

      Affiliations

    • Department of Surgery, University of Colorado Denver, Denver, CO
    • Corresponding Author InformationCorrespondence address: Joel M Baumgartner, MD, Department of Surgery, University of Colorado Denver, 4200 E 9th Ave C-320, Denver, CO 80262.
    • ,
  • Christopher C. Silliman, MD, PhD

      Affiliations

    • Department of Pediatrics, Bonfils Blood Center, Denver, CO
    • ,
  • Ernest E. Moore, MD, FACS

      Affiliations

    • Department of Surgery, University of Colorado Denver, Denver, CO
    • ,
  • Anirban Banerjee, PhD

      Affiliations

    • Department of Surgery, University of Colorado Denver, Denver, CO
    • ,
  • Martin D. McCarter, MD, FACS

      Affiliations

    • Department of Surgery, University of Colorado Denver, Denver, CO

Received 20 June 2008 ,Revised 16 August 2008 ,Accepted 18 August 2008.

References 

  1. Moore FA, Moore EE, Sauaia A. Blood transfusion (An independent risk factor for postinjury multiple organ failure). Arch Surg. 1997;132:620–624discussion 624−625
  2. Silliman CC, McLaughlin NJ. Transfusion-related acute lung injury. Blood Rev. 2006;20:139–159
  3. Opelz G, Sengar DP, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc. 1973;5:253–259
  4. Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 2006;CD005033.
  5. Peters WR, Fry RD, Fleshman JW, Kodner IJ. Multiple blood transfusions reduce the recurrence rate of Crohn's disease. Dis Colon Rectum. 1989;32:749–753
  6. Chang H, Hall GA, Geerts WH, et al. Allogeneic red blood cell transfusion is an independent risk factor for the development of postoperative bacterial infection. Vox Sang. 2000;78:13–18
  7. Kristiansson M, Soop M, Shanwell A, Sundqvist KG. Prestorage versus bedside white blood cell filtration of red blood cell concentrates: effects on the content of cytokines and soluble tumor necrosis factor receptors. J Trauma. 1996;40:379–383
  8. Mynster T, Dybkjoer E, Kronborg G, Nielsen HJ. Immunomodulating effect of blood transfusion: is storage time important?. Vox Sang. 1998;74:176–181
  9. Silliman CC, Voelkel NF, Allard JD, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest. 1998;101:1458–1467
  10. Nielsen HJ, Reimert CM, Pedersen AN, et al. Time-dependent, spontaneous release of white cell- and platelet-derived bioactive substances from stored human blood. Transfusion. 1996;36:960–965
  11. Shanwell A, Kristiansson M, Remberger M, Ringden O. Generation of cytokines in red cell concentrates during storage is prevented by prestorage white cell reduction. Transfusion. 1997;37:678–684
  12. Ghio M, Contini P, Mazzei C, et al. In vitro immunosuppressive activity of soluble HLA class I and Fas ligand molecules: do they play a role in autologous blood transfusion?. Transfusion. 2001;41:988–996
  13. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev. 2007;21:327–348
  14. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005;6:345–352
  15. Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol. 2006;24:209–226
  16. Dieckmann D, Plottner H, Berchtold S, et al. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med. 2001;193:1303–1310
  17. Tang Q, Bluestone JA. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol. 2008;9:239–244
  18. Venet F, Chung CS, Monneret G, et al. Regulatory T cell populations in sepsis and trauma. J Leukoc Biol. 2008;83:523–535
  19. MacConmara MP, Maung AA, Fujimi S, et al. Increased CD4+ CD25+ T regulatory cell activity in trauma patients depresses protective Th1 immunity. Ann Surg. 2006;244:514–523
  20. Kobayashi N, Hiraoka N, Yamagami W, et al. FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res. 2007;13:902–911
  21. Miracco C, Mourmouras V, Biagioli M, et al. Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma. Oncol Rep. 2007;18:1115–1122
  22. Griffiths RW, Elkord E, Gilham DE, et al. Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival. Cancer Immunol Immunother. 2007;56:1743–1753
  23. Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004;10:942–949
  24. McCarter MD, Baumgartner J, Escobar GA, et al. Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients. Ann Surg Oncol. 2007;14:2854–2860
  25. Boschiero L, Nacchia F, Fior F, et al. Specific alloantigen self-control by regulatory T cells in organ transplantation: a review. Transplant Proc. 2007;39:2013–2017
  26. Brecher ME. Technical manual, AABB. 15th ed.. Bethesda, MD: American Association of Blood Banks; 2005;
  27. Hughes A, Mijovic V, Brozovic B, Davies TD. Leucocyte-depleted blood: a comparison of cell-washing techniques. Vox Sang. 1982;42:145–150
  28. Rock G, Baxter A, Gray E. Leukocyte-depleted blood: a comparison of available preparations. Can Med Assoc J. 1984;130:1566–1568
  29. Uda M, Naito S, Yamamoto K, et al. Optimal protocol for preparation of leukocyte-poor red cells with a blood cell processor. Transfusion. 1984;24:120–123
  30. Gavin MA, Torgerson TR, Houston E, et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci U S A. 2006;103:6659–6664
  31. Roncador G, Brown PJ, Maestre L, et al. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol. 2005;35:1681–1691
  32. Fritzsching B, Oberle N, Eberhardt N, et al. In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand— but not to TCR-mediated cell death. J Immunol. 2005;175:32–36
  33. Roelen D, Brand A, Claas FH. Pretransplant blood transfusions revisited: a role for CD(4+) regulatory T cells?. Transplantation. 2004;77(Suppl):S26–S28
  34. Claas FH, Roelen DL, van Rood JJ, Brand A. Modulation of the alloimmune response by blood transfusions. Transfus Clin Biol. 2001;8:315–317
  35. Lapierre V, Auperin A, Robinet E, et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion. 2007;47:1691–1699
  36. Fu S, Zhang N, Yopp AC, et al. TGF-beta induces Foxp3+ T-regulatory cells from CD4+ CD25− precursors. Am J Transplant. 2004;4:1614–1627
  37. Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med. 2008;358:1229–1239
  38. Tinmouth A, Fergusson D, Yee IC, Hebert PC. Clinical consequences of red cell storage in the critically ill. Transfusion. 2006;46:2014–2027
  39. Wadhwa M, Seghatchian MJ, Dilger P, et al. Cytokine accumulation in stored red cell concentrates: effect of buffy-coat removal and leucoreduction. Transfus Sci. 2000;23:7–16
  40. Blajchman MA. The clinical benefits of the leukoreduction of blood products. J Trauma. 2006;60(Suppl):S83–S90
  41. Bilgin YM, van de Watering LM, Eijsman L, et al. Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery. Circulation. 2004;109:2755–2760
  42. Opelz G, Vanrenterghem Y, Kirste G, et al. Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation. 1997;63:964–967
  43. Vamvakas EC. Meta-analysis of randomized controlled trials investigating the risk of postoperative infection in association with white blood cell-containing allogeneic blood transfusion: the effects of the type of transfused red blood cell product and surgical setting. Transfus Med Rev. 2002;16:304–314
  44. Bordin JO, Bardossy L, Blajchman MA. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: the importance of the timing of the leukodepletion. Blood. 1994;84:344–348
  45. MacLennan S, Williamson LM. Risks of fresh frozen plasma and platelets. J Trauma. 2006;60(Suppl):S46–S50
  46. Haas J, Fritzsching B, Trubswetter P, et al. Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J Immunol. 2007;179:1322–1330
  47. Sarkar S, Fox DA. Regulatory T cell defects in rheumatoid arthritis. Arthritis Rheum. 2007;56:710–713
  48. Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol. 2003;15:430–435
  49. Perez SA, Karamouzis MV, Skarlos DV, et al. CD4+CD25+ regulatory T-cell frequency in HER-2/neu (HER)-positive and HER-negative advanced-stage breast cancer patients. Clin Cancer Res. 2007;13:2714–2721
  50. Demirkiran A, Kok A, Kwekkeboom J, et al. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Liver Transpl. 2006;12:277–284

 Disclosure Information: Nothing to disclose.

PII: S1072-7515(08)01269-6

doi: 10.1016/j.jamcollsurg.2008.08.012

Journal of the American College of Surgeons
Volume 208, Issue 1 , Pages 110-119 , January 2009

Article Tools

* Image Usage & Resolution